INOVAIT and the Government of Canada announced a major investment in the field of image-guided therapy (IGT), with up to $22.7 million in contributions committed to 14 commercialization-focused R&D projects under INOVAIT’s Focus Fund program.
The Focus Fund investment will support three-year projects at the intersection of advanced imaging, minimally-invasive surgery and artificial intelligence. These innovations will use advances in data sciences and artificial intelligence to enhance image guidance and corresponding therapies. The resulting technologies have the potential to greatly improve patient outcomes and reduce the overall cost of healthcare in Canada.
Congratulations to these OBIO® members and affiliated companies - Arrayus Technologies Inc., Conavi Medical, Cosm Medical, 16 Bit and Synaptive Medical Inc. - on receiving funding from INOVAIT and Government of Canada.